openPR Logo
Press release

Pulmonary Arterial Hypertension (PAH) Market Revenue, Industry Growing Demand, Top Companies, Regional Outlook Up To 2027

06-09-2021 10:33 AM CET | Health & Medicine

Press release from: Orion Market Reports

The Pulmonary Arterial Hypertension (PAH) Market is expected to gain market growth in the forecast period of 2021 to 2027. The market is growing with a CAGR of 8% in the forecast period of 2021 to 2027.

Pulmonary arterial hypertension (PAH) is a form of a condition known as pulmonary hypertension, which means high blood pressure in the lungs. PAH is characterized by increased pressure within the pulmonary artery due to structural changes within the vessel wall, aggregation of platelets, and changes in somatic function, resulting in increased pressure within the pulmonary artery, which is imposed on pumping blood into the lungs. Consumers' daily changes in terms of lack of physical activity and greater consumption of alcohol, tobacco, and fast food products increase their chances of developing high blood pressure and high blood pressure. Elevated blood pressure causes several diseases, such as stroke and heart attack. Treatment of pulmonary arterial hypertension can be done with drugs such as endothelin receptor antagonists, prostacyclins and prostacyclin analogs, soluble guanylate cyclase stimulants, and phosphodiesterase type 5 inhibitors.

(Get 15% Discount on Buying this Report)
A full report of Global Pulmonary Arterial Hypertension (PAH) Market is available at: https://www.orionmarketreports.com/pulmonary-arterial-hypertension-pah-market/56626/

Market Segments

By Drug Type
• Endothelin Receptor Antagonists (ERAs)
• Prostacyclin and Prostacyclin Analogs
• sGC Stimulators
• PDE-5 Dipsticks

By Sales Channel
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

Key Players

Key players in the PAH market include Johnson & Johnson Services, Inc. (Actelion Pharmaceuticals, Ltd.); Novartis International AG; Gilead Sciences, Inc.; United Therapeutics Corporation; GlaxoSmithKline plc (GSK); Pfizer, Inc.; Dong-A ST Co., Ltd.; Merck Sharp & Dohme Corp; Bayer HealthCare; and Arena Pharmaceuticals.

Scope of the Report

The research study analyzes the global Pulmonary Arterial Hypertension (PAH) industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Pulmonary Arterial Hypertension (PAH) Market Report

1. What was the Pulmonary Arterial Hypertension (PAH) Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027).
2. What will be the CAGR of the Pulmonary Arterial Hypertension (PAH) Market during the forecast period (2021-2027)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
4. Which manufacturer/vendor/players in the Pulmonary Arterial Hypertension (PAH) Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.

The report covers the following objectives:

• Proliferation and maturation of trade in the global Pulmonary Arterial Hypertension (PAH) market.
• The market share of the global Pulmonary Arterial Hypertension (PAH) market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Pulmonary Arterial Hypertension (PAH) market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Pulmonary Arterial Hypertension (PAH) market.

Media Contact:

Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404

About Us:

Orion Market Reports (OMR) endeavors to provide an exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and the most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pulmonary Arterial Hypertension (PAH) Market Revenue, Industry Growing Demand, Top Companies, Regional Outlook Up To 2027 here

News-ID: 2301251 • Views: 453

More Releases from Orion Market Reports

Robe Hooks Market is Anticipated to Increase at a Stable CAGR over the Forecast …
The Robe Hooks Market size is expected to grow at an annual average of CAGR 5% during the forecast period (2022-2028). Robe hooks are used to hang clothes such as robes, towels, or other items of clothing. Robe hooks are simple hand-held devices usually constructed of metal and plastic materials. Robe hooks have two ends. This means that one end will hold your clothes and the other end will help
Radiation Shielding Windows Market to Signify Strong Growth by 2022-2028
The Radiation Shielding Windows Market size is expected to grow at an annual average of CAGR 5% during the forecast period (2022-2028). Radiation shielding windows are commonly used with lead-lined window frames to provide complete protection without gaps in the shielding while allowing visibility of the processes taking place in the shielded space. Radiation shielding glass is available in several density ranges to accommodate the needs of different radiation processes. Market
Optical Coherence Tomographer Market Is Likely to Experience a Tremendous Growth …
The Optical Coherence Tomographer Market size is expected to grow at an annual average of CAGR 14% during the forecast period (2022-2028). Optical coherence tomography (OCT) has become the gold standard imaging modality for monitoring the posterior segment of the eye. It is a non-invasive imaging technique that uses reflected light to create two- and three-dimensional pictures of deep structures, such as the back of the human eye. Market experts make
Automotive Sensor Market to Witness Robust Expansion by 2028
The global automotive sensor market size was valued at USD 37.9 billion in 2021 and is expected to hit around USD 67.2 billion by 2028, expanding growth at a notable CAGR of 6% from 2022 to 2028. Automotive sensors are used to improve driver's safety and comfort especially in commercial and luxury vehicles. Automotive sensors also boost performance and fuel efficiency in high performance cars. Rise in standard of living and

All 5 Releases


More Releases for PAH

Development: Pulmonary Arterial Hypertension (PAH) Market Growth Analysis
The global pulmonary arterial hypertension (pah) market is estimated to surpass $9,670.2 million by 2027, exhibiting a CAGR of 5.8% from 2020 to 2027. The report provides all-inclusive analysis of global pulmonary arterial hypertension (pah) market with comprehensive study of the various facets of the market including market dynamics, major segments and regions, top leading players, and competitive landscape. Research Methodology Research Dive offers its clients extensive research and analysis gleaned from wide
Pulmonary Arterial Hypertension (PAH) Market Research and Clinical Analysis 2020
Global Pulmonary Arterial Hypertension (PAH) Market research report published by market insight reports explores the current outlook in global and key regions from the perspective of Major Players, Countries, Product types and end industries. This report analyzes top players in the global market, and divides the Market into several parameters. This Pulmonary Arterial Hypertension (PAH) Market research report identifies the competitive landscape of industries to understand the competition at International level.
Pulmonary Arterial Hypertension (PAH) Medicine Market (2020-2027) Report Offers …
The research study includes the latest updates about the COVID-19 impact on the Pulmonary Arterial Hypertension (PAH) Medicine sector. The outbreak has broadly influenced the global economic landscape. The report contains a complete breakdown of the current situation in the ever-evolving business sector and estimates the aftereffects of the outbreak on the overall economy. The market research report on the global Pulmonary Arterial Hypertension (PAH) Medicine market provides an extensive and
Pulmonary Arterial Hypertension (PAH) - Market Outlook and Competitive Landscape …
Report Overview  The report provides a comprehensive view of disease events, types, severity, progression, symptoms, risk factors, pathogenesis and treatment guidelines at country level  Comprehensive insight on patient segmentation has been provided into the epidemiology of the Pulmonary Arterial Hypertension (PAH) and its treatment in the 8 MM countries, covering the United States, EU5 (Germany, Spain, France, Italy, UK), Japan, and China  Drug utilization and analysis on the current
Global Pulmonary Arterial Hypertension (PAH) Market| MarketResearchReports.biz
Latest industry research report on: Global Pulmonary Arterial Hypertension (PAH) Market : Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of the global Pulmonary Arterial Hypertension (PAH) market on the basis of Drug Class (Endothelin Receptor Antagonists, Prostacyclin, Prostacyclin Analogs, Phosphodiesterase V
Pulmonary Arterial Hypertension (PAH) Market by Key Players 
Global Pulmonary Arterial Hypertension (PAH) Market: Snapshot Pulmonary arterial hypertension (PAH) is a very rare type of progressive disorder related to high blood pressure. However, the rate of incidence of this disorder is gradually gaining traction. Various sources, including WHO and CDC, suggest that the global prevalence of PAH is anticipated to be between 100,000 and 200,000, narrowing down to about 15-50 cases per million heads. There is no permanent cure